Impurity Profiling Suite
Advanced Chemistry Development, Inc., (ACD/Labs)Predict Genotoxic & Carcinogenic Endpoints to Meet ICH M7 Guidelines
Products, services, reviews and techniques used in lead molecule testing in humans through clinical trials and regulatory services, and data analysis.
Predict Genotoxic & Carcinogenic Endpoints to Meet ICH M7 Guidelines
Megarobo's new MRA-LSF-840 series ultra-high-throughput kit assembly system can meet the needs of reagent card assembly in terms of throughput, compatibility, and yield. At the same time, it is equipped with card loading and packaging modules, and each module can be operated independently or combined for production.
Efficient: Up to 8000-10000 pcs/h Flexible: Compatible with multiple types of tubes such as disposable virus sampling tubes Intuitive: Visualization software & touch screen Modular: Including laminar flow, labeling and coding, and CCD modules, allows for personalization Stable: Stable operation, high yield rate Effortless: Only 1 -2 people are needed to complete the whole process
Efficient: Up to 8000-10000 pcs/h Flexible: Compatible with multiple types of tubes such as disposable virus sampling tubes Intuitive: Visualization software & touch screen Modular: Including laminar flow, labeling and coding, and CCD modules, allows for personalization Stable: Stable operation, high yield rate Effortless: Only 1 -2 people are needed to complete the whole process
The Micronic 1.40ml internally threaded screw cap tubes are available with a V- or U-shaped interior bottom.
Learn how to perform a gap analysis of laboratory quality activities to help your laboratory meet minimum QMS requirements.
QPS Global Custom-Built Regulatory Services Can Transform Clinical Trials. QPS Global Regulatory Affairs (GRA) service offerings focus on helping pharmaceutical, biotechnology, and medical device companies to develop custom-built research solutions that forge expedited regulatory pathways from discovery to global commercialization and onwards through product lifecycle support.
Moving quickly and safely through Phase I/IIa trials is critical to successful drug development. The QPS Phase I research facilities feature more than 550 beds across six strategically located facilities on three continents. QPS is well known for its success in first-in-human clinical trials. All Phase I sites are staffed by expert clinical pharmacology teams that routinely conduct hundreds of phase I/IIa studies annually.
At QPS, we realize that in today’s late stage drug development space you face many challenges. With our deep experience and broad global presence, QPS is in an excellent position to offer solutions to all of the above needs. With its site management & monitoring teams operating from 30 locations on three continents (Asia/Pacific, USA, and Europe), QPS has become a new strong player in Phase II/IV clinical research services.…